Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2020

01-07-2020 | Breast Cancer | Original Research

Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey

Authors: Kelly A. Kyanko, MD, MHS, Jessica Hoag, PhD, Susan H. Busch, PhD, Jenerius A. Aminawung, MD, MPH, Xiao Xu, PhD, Ilana B. Richman, MD, Cary P. Gross, MD

Published in: Journal of General Internal Medicine | Issue 7/2020

Login to get access

Abstract

Background

To date, 38 states have enacted dense breast notification (DBN) laws mandating that mammogram reports include language informing women of risks related to dense breast tissue.

Objective

Nationally representative survey to assess the association between residing in a state with a DBN law and women’s awareness and knowledge about breast density, and breast cancer anxiety.

Design

Internet survey conducted in 2018 with participants in KnowledgePanel®, an online research panel.

Participants

English-speaking US women ages 40–59 years without a personal history of breast cancer who had received at least one screening mammogram (N = 1928; survey completion rate 68.2%).

Main Measures

(1) Reported history of increased breast density, (2) knowledge of the increased risk of breast cancer with dense breasts, (3) knowledge of the masking effect of dense breasts on mammography, and (4) breast cancer anxiety.

Key Results

Women residing in DBN states were more likely to report increased breast density (43.6%) compared with women residing in non-DBN states (32.7%, p < 0.01, adjusted odds ratio, 1.70, 95% CI,1.34–2.17). Interaction effect between DBN states and education status showed that the impact of DBN on women’s reporting of dense breasts was significant for women with greater than high school education, but not among women with a high school education or less (p value = 0.01 for interaction). Only 23.0% of women overall knew that increased breast density was associated with a higher risk of breast cancer, and 68.0% of women understood that dense breasts decreased the sensitivity of mammography. There were no significant differences between women in DBN states and non-DBN states for these outcomes, or for breast cancer–related anxiety.

Conclusions

State DBN laws were not associated with increased understanding of the clinical implications of breast density. DBN laws were associated with a higher likelihood of women reporting increased breast density, though not among women with lower education.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. Journal of the National Cancer Institute. 2014;106(10). Sprague BL, Gangnon RE, Burt V, et al. Prevalence of mammographically dense breasts in the United States. Journal of the National Cancer Institute. 2014;106(10).
2.
go back to reference Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Annals of Internal Medicine. 2012;156(9):635–648. Nelson HD, Zakher B, Cantor A, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Annals of Internal Medicine. 2012;156(9):635–648.
3.
go back to reference Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Annals of Internal Medicine. 2011;155(8):493–502. Kerlikowske K, Hubbard RA, Miglioretti DL, et al. Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Annals of Internal Medicine. 2011;155(8):493–502.
5.
go back to reference Haas JS, Kaplan CP. The divide between breast density notification laws and evidence-based guidelines for breast cancer screening: legislating practice. JAMA Internal Medicine. 2015;175(9):1439–1440. Haas JS, Kaplan CP. The divide between breast density notification laws and evidence-based guidelines for breast cancer screening: legislating practice. JAMA Internal Medicine. 2015;175(9):1439–1440.
6.
go back to reference Slanetz PJ, Freer PE, Birdwell RL. Breast-density legislation—practical considerations. New England Journal of Medicine. 2015;372(7):593–595.CrossRef Slanetz PJ, Freer PE, Birdwell RL. Breast-density legislation—practical considerations. New England Journal of Medicine. 2015;372(7):593–595.CrossRef
7.
go back to reference Keating NL, Pace LE. New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients? JAMA. 2019. Keating NL, Pace LE. New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients? JAMA. 2019.
8.
go back to reference Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. JAMA. 2016;315(16):1786–1788. Kressin NR, Gunn CM, Battaglia TA. Content, readability, and understandability of dense breast notifications by state. JAMA. 2016;315(16):1786–1788.
9.
go back to reference Gunn CM, Battaglia TA, Paasche-Orlow MK, West AK, Kressin NR. Women’s perceptions of dense breast notifications in a Massachusetts safety net hospital:“So what is that supposed to mean?”. Patient education and counseling. 2018;101(6):1123–1129.CrossRef Gunn CM, Battaglia TA, Paasche-Orlow MK, West AK, Kressin NR. Women’s perceptions of dense breast notifications in a Massachusetts safety net hospital:“So what is that supposed to mean?”. Patient education and counseling. 2018;101(6):1123–1129.CrossRef
10.
go back to reference Jemal A, Ward E, Henley J, et al. Cancer Mortality in the United States by Education Level and Race. Journal of the National Cancer Institute. 2007;99(18):1384–1394. Jemal A, Ward E, Henley J, et al. Cancer Mortality in the United States by Education Level and Race. Journal of the National Cancer Institute. 2007;99(18):1384–1394.
11.
go back to reference Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117(7):1542–1551.CrossRef Sprague BL, Trentham-Dietz A, Gangnon RE, et al. Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer. 2011;117(7):1542–1551.CrossRef
13.
go back to reference Rhodes DJ, Breitkopf CR, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. Journal of Clinical Oncology. 2015;33(10):1143.CrossRef Rhodes DJ, Breitkopf CR, Ziegenfuss JY, Jenkins SM, Vachon CM. Awareness of breast density and its impact on breast cancer detection and risk. Journal of Clinical Oncology. 2015;33(10):1143.CrossRef
14.
go back to reference Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. Journal of the American College of Radiology. 2019;16(2):139–146.CrossRef Cappello NM, Richetelli D, Lee CI. The Impact of Breast Density Reporting Laws on Women’s Awareness of Density-Associated Risks and Conversations Regarding Supplemental Screening With Providers. Journal of the American College of Radiology. 2019;16(2):139–146.CrossRef
15.
go back to reference Guterbock TM, Cohn WF, Rexrode DL, et al. What do women know about breast density? Results from a population survey of Virginia women. Journal of the American College of Radiology. 2017;14(1):34–44.CrossRef Guterbock TM, Cohn WF, Rexrode DL, et al. What do women know about breast density? Results from a population survey of Virginia women. Journal of the American College of Radiology. 2017;14(1):34–44.CrossRef
16.
go back to reference Houssami N, Lee CI. The impact of legislation mandating breast density notification - Review of the evidence. Breast (Edinburgh, Scotland). 2018;42:102–112.CrossRef Houssami N, Lee CI. The impact of legislation mandating breast density notification - Review of the evidence. Breast (Edinburgh, Scotland). 2018;42:102–112.CrossRef
17.
go back to reference Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Academic Radiology Jun 2019;26(6):726–731. Miles RC, Lehman C, Warner E, Tuttle A, Saksena M. Patient-Reported Breast Density Awareness and Knowledge after Breast Density Legislation Passage. Academic Radiology Jun 2019;26(6):726–731.
18.
go back to reference Willis GB. Cognitive interviewing: A tool for improving questionnaire design. Sage Publications; Thousand Oaks 2004. Willis GB. Cognitive interviewing: A tool for improving questionnaire design. Sage Publications; Thousand Oaks 2004.
19.
go back to reference Yeager DS, Krosnick JA, Chang L, et al. Comparing the accuracy of RDD telephone surveys and internet surveys conducted with probability and non-probability samples. Public Opinion Quarterly. 2011;75(4):709–747. Yeager DS, Krosnick JA, Chang L, et al. Comparing the accuracy of RDD telephone surveys and internet surveys conducted with probability and non-probability samples. Public Opinion Quarterly. 2011;75(4):709–747.
22.
go back to reference Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value in health. 2007;10(4):294–304.CrossRef Brodersen J, Thorsen H, Kreiner S. Validation of a condition-specific measure for women having an abnormal screening mammography. Value in health. 2007;10(4):294–304.CrossRef
23.
go back to reference Norton EC, Dowd BE, Maciejewski ML. Marginal Effects—Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models. JAMA. 2019: 321:1304-1305CrossRef Norton EC, Dowd BE, Maciejewski ML. Marginal Effects—Quantifying the Effect of Changes in Risk Factors in Logistic Regression Models. JAMA. 2019: 321:1304-1305CrossRef
24.
go back to reference Smetana GW, Elmore JG, Lee CI, Burns RB. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine. 2018;169(7):474–484. Smetana GW, Elmore JG, Lee CI, Burns RB. Should This Woman With Dense Breasts Receive Supplemental Breast Cancer Screening?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center. Annals of Internal Medicine. 2018;169(7):474–484.
25.
go back to reference Kindig DA, Panzer AM, Nielsen-Bohlman L. Health literacy: a prescription to end confusion. National Academies Press; Washington, D. C. 2004. Kindig DA, Panzer AM, Nielsen-Bohlman L. Health literacy: a prescription to end confusion. National Academies Press; Washington, D. C. 2004.
Metadata
Title
Dense Breast Notification Laws, Education, and Women’s Awareness and Knowledge of Breast Density: a Nationally Representative Survey
Authors
Kelly A. Kyanko, MD, MHS
Jessica Hoag, PhD
Susan H. Busch, PhD
Jenerius A. Aminawung, MD, MPH
Xiao Xu, PhD
Ilana B. Richman, MD
Cary P. Gross, MD
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05590-7

Other articles of this Issue 7/2020

Journal of General Internal Medicine 7/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.